CONTINUING TO SUPPORT THE NATION'S EMERGING SECTORS
As an innovative financier and development facilitator of the ICT sector, MDV is now extending its portfolio into the rapidly emerging biotechnology sector. MDV has established its own independent team of credit and research professionals and a dedicated fund towards advancing this vibrant sector as one of the main engines of growth for the nation's economy.
Your independent vision and leadership with full control.
Building a company takes enormous effort and determination from the start. It will ultimately be your vision and leadership that will lead your company to success. MDV takes no stake in your company. Instead we offer the following advantages compared to venture capitalists and other financiers:
* Clear and transparent exit mechanism i.e. repayment of financing
* Flexible repayment periods
* Independent of stock market conditions
* Independent of your company valuation
* Maximising returns to shareholders, including existing Venture Capital investors
Your application process is accelerated due to our highly-efficient procedures. Upon securing your Biotech project, you would want someone to act on it fast. With complete documentation, we will process your application within a short timeframe. Biotech projects are very time-sensitive and work best when implemented within a specific window of opportunity. Due to our in-depth knowledge of the industry and highly-effective procedures, MDV works fast so that you can realise maximum potential returns from your project earlier.
We are behind you every step of the way
When you look for a financial partner, you want someone who gives you full support. We have the financial muscle to give your business the boost it needs. But that's not all. MDV is prepared to give you access to specialised value-added services that will develop and enhance your Biotech business.
MDV PRODUCT OFFERINGS
CONTRACT/PROJECT FINANCING-i
For open-ended projects or projects that are dependent on medium to long-term contracts from sponsors, we offer financing for the purchase of the project's major inputs.
* Financing up to RM 120 million
* Financing margin of up to 85% and tenure of up to 120 months
EQUIPMENT & INFRASTRUCTURE FINANCING-i
To finance acquisition and construction of land/building, equipment and fittings for laboratory; and R&D and/or manufacturing facilities.
* Financing up to RM 120 million
* Financing margin of up to 85% and tenure of up to 120 months
Working Capital Financing-i
To fund purchases of business assets to meet business expenses, in particular to enable applicants to meet their operating expenses, purchase inventory and financing receivables.
* Financing up to RM 50 million
* Financing margin of up to 85% and tenure of up to 36 months (subject to annual review)
* All MDV products are based on the Murabaha concept of financing
* Term and condition apply
MDV BIOTECHNOLOGY FOCUS AREAS
* Natural Products - Use of Agri- and/or Healthcare Biotechnology
* Medical Devices and Diagnostics
* Contract Manufacturing Organisations
* Contract Research Organisations
* Industrial Biotechnology
* Bio-Informatics
ELIGIBILITY CRITERIA
* Commercial-stage Biotechnology and Life Sciences companies that are involved in MDV Focus Areas
* Strong Management and Technical Team
* Attractive Underlying Markets
* Technology and Product Leadership with clear sources of differentiation and competitiveness
* Maintenance of Malaysian presence
BENEFITS OF MDV FINANCING
* MDV Financing allows preservation of cash and capital
* Effective tool to bridge a company's cash position
* Reduction of weighted average cost of capital
* Funding growth without diluting shareholder's ownership
Loading...
10:01
Biotechnology & Gene Therapyby dremchyld104,446 views
Buy BTX and ACTC.
krankfoller 1 year ago